Dee Conger

Dee Conger founded Innovive, Inc. in 2004 to radically transform the economics and convenience of conducting laboratory research. Before Innovive, he served as CEO of Ansata Therapeutics, a large molecule discovery operation focused on broad-spectrum antimicrobial compounds. Before Ansata, Dee served as Vice President, Strategic Operations at Vertex Pharmaceuticals. He was responsible for all discovery operations, including Compound Management, Cell Core, Quality Assurance, and HTS/UHTS screening at their San Diego site.

Dee also worked as a consultant with the Boston Consulting Group. He received an MBA and a Master's of industrial engineering from the Kellogg Graduate School of Management and McCormick School of Engineering and Applied Science at Northwestern University with the highest honors. Dee also served as a combat fighter pilot and instructor pilot in the NATO fighter pilot school in the United States Air Force. He is the first inventor of more than 40 US and international patents and holds many US and international trademarks. In his spare time, Dee continues to restore and fly various aircraft and is FAA-type rated in the A-4, F-5, F-4, T-37, T-38, S211, Fouga Magistre, and different Learjet models.